HEXAGON BIO
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
HEXAGON BIO
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.hexagonbio.com
Total Employee:
11+
Status:
Active
Total Funding:
116.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Column Group
The Column Group investment in Series B - Hexagon Bio
Two Sigma Ventures
Two Sigma Ventures investment in Series B - Hexagon Bio
Nextech Invest
Nextech Invest investment in Series B - Hexagon Bio
Casdin Capital
Casdin Capital investment in Series B - Hexagon Bio
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Hexagon Bio
8VC
8VC investment in Series B - Hexagon Bio
LeFrak
LeFrak investment in Series A - Hexagon Bio
Two Sigma Ventures
Two Sigma Ventures investment in Series A - Hexagon Bio
The Column Group
The Column Group investment in Series A - Hexagon Bio
8VC
8VC investment in Series A - Hexagon Bio
Official Site Inspections
http://www.hexagonbio.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hexagon Bio"
Company - Hexagon
Tara is Chief Scientific Officer at Hexagon Bio. She previously served as Hexagon’s Senior Vice President, Research. Prior to joining Hexagon, Tara was an Executive Director of Oncology …See details»
Hexagon Bio Company Profile 2024: Valuation, Funding …
Www.hexagonbio.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 1490 O'Brien Drive; Suite E; Menlo Park, CA 94025; United StatesSee details»
Hexagon Bio Raises $77.3 Million Series B Financing and …
Feb 13, 2023 “We are excited to now have Tara fully at the helm of our scientific organization as we continue to expand our platform’s capabilities and advance toward development candidate …See details»
Hexagon Bio - Crunchbase Company Profile & Funding
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences.See details»
Hexagon Bio - LinkedIn
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and ...See details»
Hexagon Bio Information - RocketReach
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, …See details»
Hexagon Bio - VentureRadar
"Hexagon Bio is a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome. The company’s highly interdisciplinary platform uses data science, …See details»
Hexagon Bio: Contact Details, Revenue, Funding, Employees and …
Hexagon Bio is a biopharma company using data science, genomics, and synthetic biology to develop targeted small molecule therapeutics. By mining fungal genomes, they aim to discover …See details»
Hexagon Bio Raises $77.3 Million Series B Financing and …
Feb 13, 2023 Hexagon’s interdisciplinary platform enables broad opportunities across multiple therapeutic areas; company initially focused on oncology and infectious diseasesTara …See details»
Hexagon Bio Appoints Yujiro Hata to Board of Directors
Nov 26, 2024 Hexagon Bio is advancing a pipeline of next-generation ADC candidates with novel payloads designed to treat a wide range of solid tumors and hematological …See details»
Hexagon Bio Company Profile | Management and Employees List
[email protected]: Hexagon Bio Top Competitors. Company Employees Revenue Top technologies; Alion Pharmaceuticals. 17: $6.1 M: Frost Biologic. 13: $3.2 M: Astex …See details»
Hexagon Bio - Overview, News & Similar companies - ZoomInfo
Feb 12, 2023 View Hexagon Bio (www.hexagonbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Hexagon Bio Company Overview, Contact Details & Competitors
Oct 11, 2022 Hexagon Bio. Biotechnology Research California, United States 51-200 Employees. Hexagon Bio is a data-driven biopharma company developing targeted small …See details»
Hexagon Bio Raises $77.3 Million Series B Financing and
Feb 14, 2023 Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised a $77.3 million Series …See details»
Hexagon Bio Raises $77.3 Million Series B Financing and
Feb 13, 2023 Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived …See details»
Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule ...
Sep 22, 2021 Learn more at hexagonbio.com. *As of the date of this press release, SoftBank Group Corp. has made capital contributions to allow investments by SoftBank Vision Fund 2 …See details»
Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen …
Mar 21, 2022 Hexagon Bio CEO Maureen Hillenmeyer, PhD. Long before today’s aerospace engineers fashioned rockets and space telescope mirrors, bees were using the hexagonal …See details»
Science - Hexagon
Our proprietary genome database is expanding, with over 100,000 organismal strains banked, and over 80,000 genomes sequenced. Our platform predicts several hundred potential ADC …See details»
News - Hexagon
Feb 13, 2023 In this episode, Hillenmeyer explains how Hexagon is using genomic sequencing and artificial intelligence to analyze the millions of types of fungi on earth and uncover new …See details»